Conformational mapping of a viral fusion peptide in structure-promoting solvents using circular dichroism and electrospray mass spectrometry

Proteins: Structure, Function and Genetics

Volumn 33, Issue SUPPL. 2, 1998, Pages 38-49

  Waring, Alan J ^a,c   Mobley, Patrick W ^b   Gordon, Larry M ^a  

^a KING DREW MEDICAL CENTER   (United States)

^b CALIFORNIA STATE POLYTECHNIC UNIVERSITY   (United States)

^c Research and Education Institute   (United States)

Author keywords

CD; Glycoprotein 41,000 (gp41); Human immunodeficiency virus (HIV); MS MS electrospray mass spectrometry; N terminal domain

Indexed keywords

DEUTERIUM; GLYCOPROTEIN GP 41; HYBRID PROTEIN; SOLVENT; TRIFLUOROETHANOL; VIRUS GLYCOPROTEIN; VIRUS PROTEIN; PEPTIDE FRAGMENT;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANALYTIC METHOD; ARTICLE; CIRCULAR DICHROISM; HUMAN IMMUNODEFICIENCY VIRUS; MASS SPECTROMETRY; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; CHEMISTRY; HUMAN; METHODOLOGY; MOLECULAR GENETICS; PEPTIDE MAPPING; PROTEIN CONFORMATION; SYNTHESIS;

AMINO ACID SEQUENCE; CIRCULAR DICHROISM; HIV ENVELOPE PROTEIN GP41; HUMANS; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PEPTIDE MAPPING; PROTEIN CONFORMATION; SOLVENTS;

EID: 0032239517     PISSN: 08873585     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0134(1998)33:2+<38::AID-PROT6>3.0.CO;2-S     Document Type: Article

References (60)

1. Myers, G., Korber, B., Berzofsky, J.A., Smith, R.F. Pavalakis, G.N. In: "Human Retroviruses and AIDS 1991: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences." Los Alamos: Los Alamos National Laboratory, 1991:II-81.
2. McCune, J.M., Rabin, L.B., Feinberg, M.B., et al. Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. Cell 53:55-67, 1988.
3. White, J. Membrane fusion. Science 258:917-924, 1992.
4. Gallaher, W.R. Detection of a fusion peptide sequence in the transmembrane protein of the human immunodeficiency virus. Cell 50:327-328, 1987.
5. Gonzalez-Scarano, F., Waxham, M.N., Ross, A.M., Hoxie, J.A. Sequence similarities between human immunodeficiency virus gp41 and paramyxovirus fusion proteins. AIDS Res. Hum. Retroviruses 3:245-252, 1987.
6. Feng, Y., Broder, C.C., Kennedy, P.E., Berger, E.A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane G protein-coupled receptor. Science 272: 872-877, 1996.
7. Trkola, A., Dragic, T., Arthos, J., et al. CD4-independent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 384:184-187, 1996.
8. Wu, L., Gerard, N.P., Wyatt, R., et al. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384:179-183, 1996.
9. Hart, T.K., Truneh, A., Bugelski, P.J. Characterization of CD4-gp120 activation intermediates during human immunodeficiency virus type 1 syncytium formation. AIDS Res. Hum. Retroviruses 12:1305-1313, 1996.
10. Chan, D.C., Fass, D., Berger, M., Kim, P.S. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89:263-273, 1997.
11. Weissenhorn, W., Dessen, A., Harrison, S.C., Skehel, J.J., Wiley, D.C. Atomic structure of the ectodomain from HIV-1 gp41. Nature 387:426-430, 1997.
12. Wingfield, P.T., Stahl, S.J., Kaufman, J., et al. The extracellular domain of immunodeficiency virus gp41 protein: expression in Escherichia coli, purification, and crystallization. Protein Sci. 6:1653-1660, 1997.
13. Bullough, P.A., Hughson, F.M., Skehel, J.J., Wiley, D.C. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371:37-43, 1994.
14. Carr, C.M., Kim, P.S. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell 73:823-832, 1993.
15. Gordon, L.M., Curtain, C.C., Zhong, Y.C., Kirkpatrick, A., Mobley, P.W., Waring, A.J. The amino terminal peptide of HIV-1 glycoprotein 41 interacts with human erythrocyte membranes: peptide conformation, orientation and aggregation. Biochim. Biophys. Acta 1139:257-274, 1992.
16. Aloia, R.C., Jensen, F.C., Curtain, C.C., Mobley, P.W., Gordon, L.M. Lipid composition and fluidity of the human immunodeficiency virus type-1. Proc. Natl. Acad. Sci. USA 85:900-904, 1988.
17. Gordon, L.M., Jensen, F.C., Curtain, C.C., Mobley, P.W., Aloia, R.C. Thermotropic lipid phase separation in the human immunodeficiency virus. Biochim. Biophys. Acta 943:331-342, 1988.
18. Felser, J., Klimkait, T., Silver, J. A syncytia assay for human immunodeficiency virus type-1 (HIV-1) envelope protein and its use in studying HIV-1 mutations. Virology 170:566-570, 1989.
19. Freed, E.O., Myers, D.J., Risser, R. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proc. Natl. Acad. Sci. USA 87:4650-4654, 1990.
20. Freed, E.O., Delwart, E.L., Buchschacher Jr., G.L., Panganiban, A.T. A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity. Proc. Natl. Acad. Sci. USA 89:70-74, 1992.
21. Bergeron, L., Sullivan, N., Sodroski, J. Target cell-specific determinants of membrane fusion within the human immunodeficiency virus type 1 gp120 third variable region and gp41 amino terminus. J. Virol. 66:2389-2397, 1992.
22. Schaal, H., Klein, M., Gerhmann, P., Adams, O., Scheid, A. Requirement of N-terminal amino acid residues of gp41 for human immunodeficiency virus type 1-mediated cell fusion. J. Virol. 69:3308-3314, 1995.
23. Delahunty, M.D., Rhee, I., Freed, E.O., Bonifacino, J.S. Mutational analysis of the fusion peptide of the human immunodeficiency virus type 1: identification of critical glycine residues. Virology 218:94-102, 1996.
24. Rafalski, M., Lear, J.D., DeGrado, W.F. Phospholipid interactions of synthetic peptides representing the N-terminus of HIV gp41. Biochemistry 29:7917-7922, 1990.
25. 2-terminal HIV-1 gp41 peptide in fused and aggregated liposomes. Biochim. Biophys. Acta 1145: 124-133, 1993.
26. Martin, I., Schall, H., Scheid, A., Ruysschaert, J.-M. Lipid membrane fusion induced by the human immunodeficiency virus type 1 and gp41 N-terminal extremity is determined by its orientation in the lipid bilayer. J. Virol. 70:298-304, 1996.
27. Nieva, J.L., Nir, S., Muga, A., Goñi, F.M., Wilschut, J. Interaction of the HIV-1 fusion peptide with phospholipid vesicles: different structural requirements for fusion and leakage. Biochemistry 33:3201-3209, 1994.
28. Pereira, F.B., Goñi, F.M., Nieva, J.L. Liposome destabilization induced by the HIV-1 fusion peptide. Effect of a single amino acid substitution. FEBS Lett. 362:243-246, 1995.
29. Pereira, F.B., Goñi, F.M., Nieva, J.L. Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: dose and sequence effects. Biophys. J. 73:1977-1986, 1997.
30. Slepushkin, V.A., Andreev, S.M., Sidorova, M.V., et al. Investigation of human immunodeficiency virus fusion peptides. Analysis of interrelations between their structure and function. AIDS Res. Hum. Retroviruses 8:9-18, 1992.
31. Terletskaya, Y.T., Trikash, I.O., Serdyuk, E.S., Andreev, S.M. Fusion of negatively charged liposomes induced by peptides of the N-terminal fragment of HIV-1 transmembrane protein. Biochemistry (Moscow) 60:1309-1314, 1995.
32. + lymphocytes. Biochim. Biophys. Acta 1139:2651-256, 1992.
33. Mobley, P.W., Lee, H.-F., Curtain, C.C., Kirkpatrick, A., Waring, A.J., Gordon, L.M. The amino-terminal peptide of HIV-1 glycoprotein 41 fuses human erythrocytes. Biochim. Biophys. Acta 1271:304-314, 1995.
34. Chang, D.-K., Chien, W.-J., Cheng, S.-F. The FLG motif in the N-terminal region of glucoprotein 41 of human immunodeficiency virus type 1 adopts a type-I β turn in aqueous solution and serves as the initiation site for helix formation. Eur. J. Biochem. 247:896-905, 1997.
35. Chang, D.-K., Cheng, S.-F., Chien, W.-J. The amino-terminal fusion domain peptide of human immunodeficiency virus type 1 gp41 inserts into the sodium dodecyl sulfate micelle primarily as a helix with a conserved glycine at the micelle-water interface. J. Virol. 71:6593-6602, 1997.
36. Thévenon-Emeric, G., Kozlowski, J., Zhang, Z., Smith, D.L. Determination of amide hydrogen exchange rates in peptides by mass spectrometry. Anal. Chem. 64:2456-2458, 1992.
37. Anderegg, R.J., Wagner, D.S., Stevenson, C.L., Borchardt, R.T. The mass spectrometry of helical unfolding in peptides. J. Am. Soc. Mass Spectrom. 5:425-433, 1994.
38. Stevenson, C.L., Anderegg, R.J., Borchardt, R.T. Probing the helical content of growth hormone-releasing factor analogs using electrospray mass spectrometry. J. Am. Soc. Mass Spectrom. 4:646-651, 1993.
39. Wagner, D.S., Melton, L.G., Yan, Y., Erickson, B.W., Anderegg, R.J. Deuterium exchange of α-helices and β-sheets as monitored by electrospray mass spectrometry. Protein Sci. 3:1305-1314, 1994.
40. Zhang, Z., Smith, D.L. Determination of amide hydrogen exchange by mass spectrometry: a new tool for protein structure elucidation. Protein Sci. 2:522-531, 1993.
41. Wagner, D.S., Anderegg, R.J. Conformation of cytochrome c studied by deuterium exchange-electrospray ionization mass spectrometry. Anal. Chem. 66:706-711, 1994.
42. Johnson, R.S., Walsh, K.A. Mass spectrometric measurement of protein amide hydrogen exchange rates of apo-and holo-myoglobin. Protein Sci. 2:522-531, 1994.
43. Resing, K.A., Ahn, N.G. Deuterium exchange mass spectrometry as a probe of protein kinase activation. Analysis of wild-type and constitutively active mutants of MAP kinase kinase-1. Biochemistry 37:463-475, 1998.
44. Wang, F., Scapin, G., Blanchard, J.S., Angeletti, R.H. Substrate binding and conformational changes of Clostridium glutamicum diaminopimelate dehydrogenase revealed by hydrogen/deuterium exchange and electrospray mass spectrometry. Protein Sci. 7:293-299, 1998.
45. Fields, C.G., Lloyd, D.H., Macdonald, R.L., Ottenson, K.M., Noble, R.L. HBTU activation for automated Fmoc solid-phase peptide synthesis. Peptide Res. 4:95-101, 1991.
46. Gordon, L.M., Waring, A.J., Curtain, C.C., et al. Antivirals that target the amino-terminal domain of HIV type 1 glycoprotein 41. AID Res. Human Retrovir. 11:677-686, 1995.
47. Gordon, L.M., Horvath, S., Longo, M.L. et al. Conformation and molecular topography of the N-terminal segment of surfactant protein B in structure-promoting environments. Protein Sci. 5:1662-1675, 1996.
48. Roepstorff, P., Fohlman, J. Proposal for a common nomenclature for sequence ions in mass spectra of peptides. Biomed. Mass Spectrom. 11:601-601, 1984.
49. Biemann, K. Tandem mass spectrometry applied to protein structure problems. Biochem. Soc. Trans. 17:237-243, 1989.
50. Waring, A.J., Faull, K.F., Leung, C., et al. Synthesis, secondary structure and folding of lung surfactant protein B. Peptide Res. 9:28-39, 1996.
51. Johnson, W.R. Jr. Protein secondary structure and circular dichroism: a practical guide. Proteins 7:205-214, 1990.
52. Chen, Y.H., Yang, J.T., Chau, K.H. Determination of the helix and β form of proteins in aqueous solution by circular dichroism. Biochemistry 13:3350-3359, 1974.
53. Perczel, A., Park, K., Fasman, G.D. Analysis of the circular dichroism spectrum of proteins using the convex constraint algorithm: a practical guide. Anal. Biochem. 203:83-93, 1992.
54. Woody, R.W. Circular dichroism of peptides. In: "The Peptides," Vol. 7. Blout, E.R., Bovey, F.A., Goodman, M., Lotan, N. (eds.). New York: Academic Press 1985:15-114.
55. Bruch, M.D., Dhingra, M.M., Gierasch, L.M. Side chain-backbone hydrogen bonding contributions to helix stability in peptides derived from an α-helical region of carboxypeptidase A. Proteins 10:130-139, 1991.
56. Johnson, R.S., Krylov, D., Walsh, K.A. Proton mobility within electrosprayed peptide ions. J. Mass Spectrom. 30:386-387, 1995.
57. Gallaher, W.R., Segrest, J.P., Hunter, E. Are fusion peptides really "sided" insertional helices? Cell 70:531-532, 1992.
58. Li, S.-C., Deber, C.M. Influence of glycine residues on peptide conformation in membrane environments. Int. J. Peptide Protein Res. 40:243-248, 1992.
59. Li, S.-C., Deber, C.M. A measure of helical propensity for amino acids in membrane environments. Struct. Biol. 1:368-373, 1994.
60. Tadesse, L., Nazarbaghi, R., Walters, L. Isotopically-enhanced infrared spectroscopy: a novel method for examining secondary structure at specific sites in conformationally heterogeneous peptides. J. Am. Chem. Soc. 113: 7036-7037, 1991.